… autoimmune blistering diseases are emerging as potential adverse events of SARS-CoV-2 …
Herein we present a new case report of PV after SARS-Cov-2 vaccination and a review of the …

… patients with blistering disorders and SARS-CoV-2 infection… SARS-CoV-2 infection. Our
primary objective in this study was to report the outcomes of patients with AIBD and SARS-CoV-2 …

… , and registries for documentation of SARS-CoV-2 infected cases. For this purpose… COVID-19,
SARS-CoV-2, coronavirus, autoimmune bullous diseases, autoimmune blistering diseases…

… coronavirus disease-2019 87 (COVID-19) among patients with autoimmune bullous skin
diseases (… We assessed the severity and mortality of COVID-19 in 89 patients with AIBD, with a …

… diagnoses may include dermatologic manifestations of herpes simplex, erythema multiforme,
autoimmune bullous diseases such as dermatitis herpetiformis and bullous pemphigoid. …

… Blistering disease in the context of COVID-19 vaccination. Erythematous, urticarial papules
and confluent plaques with admixed vesicles and erosions on the torso and extremities …

… of inflammatory and autoimmune diseases after SARS-CoV-2 vaccination was performed …
The search strategy included following terms: “COVID-19/SARS-CoV-2 vaccine bullous …

… The recovery of 17 of 19 patients with AIBD who had documented SARS‐CoV‐2 infection in
our single institution cohort, despite advanced age and comorbidities, is reassuring. The two …

… ) is a rare and severe autoimmune disorder of skin and mucosa. In … blistering and severe
erosions. Several factors including genetic susceptibility, certain drugs and malignant disorders …

… However, we did not find any preexisting conditions associated with SARS-CoV-2 infection
in this study, suggestive of a comparable population susceptibility for the omicron variant in …